WIPO Survey On Patent Filing Strategies Shows Rise In Optimism 07/02/2011 by Tavengwa Runyowa for Intellectual Property Watch Leave a Comment A recent economic survey by the World Intellectual Property Organization (WIPO) assessed the expected growth in domestic and international patent filings in 2010 compared to 2009. The highest expected growth rates were reported in Asian countries, with modest and declining growth reported in Europe and the United States respectively.
US Senate Patent Reform Steps Forward 04/02/2011 by Intellectual Property Watch 1 Comment The United States Senate Judiciary Committee yesterday approved a slightly amended version of the Patent Reform Act of 2011.
Europe Calls For Radical Change On Innovation; EU Patent In Works 02/02/2011 by William New, Intellectual Property Watch 2 Comments The European Union is failing to keep pace with key competitor nations and is in need of a radical new, greatly simplified, approach to research and innovation, the European Commission said today. And an element of what is needed is a European-wide patent.
US Legislation Would Prevent Patents On Tax Strategies 31/01/2011 by Intellectual Property Watch 4 Comments A bill was introduced into the United States Senate last week that would prevent any individual or company from being able to get a patent on a tax strategy. The bill also is included in the patent reform bill reintroduced into the Senate Judiciary Committee last week and expected to come up as soon as this week.
Innovation, Generic Drugs, Patents In Congress Follow Obama’s State of the Union Speech 28/01/2011 by Liza Porteus Viana, Intellectual Property Watch 2 Comments American lawmakers aren’t wasting any time getting down to business after President Obama stressed the importance of spurring innovation during his annual State of the Union address this week and cited the need for the United States to regain its competitive edge, particularly when up against countries such as China and India. A slew of related bills are emerging in Congress.
EU Patent Jumps Parliamentary Committee Hurdle 27/01/2011 by Intellectual Property Watch Leave a Comment A proposal for a single patent system in the European Union through an “enhanced co-operation procedure” was approved by the EU Parliament Legal Affairs Committee today.
Europe’s Outlook For 2011: EU Patent, Digital Content, Innovation And Free Trade 13/01/2011 by Dugie Standeford for Intellectual Property Watch 2 Comments The Digital Agenda’s hoped-for role as a key growth driver for Europe’s flagging economy has pushed intellectual property issues into a high-priority spot on the EU’s policy agenda for 2011. In an effort to boost job creation and innovation, the European Commission is looking to improve online content licensing, access and protection. And despite continuing opposition from several countries, the long-awaited European patent is finally moving forward. Debate is also heating up on new ways to encourage biomedical innovation, and on a proposed EU-India free trade pact.
US Supreme Court Expected To Weaken Patent Validity 12/01/2011 by Steven Seidenberg for Intellectual Property Watch 4 Comments Patents will soon receive less protection in the United States. That’s the view of many experts who have been closely following Microsoft Corp. v. i4i Ltd. Partnership, which will be argued before the United States Supreme Court later this year.
Patent Reform, Piracy, Generic Drug Issues Likely For US Congress This Year 11/01/2011 by Liza Porteus Viana, Intellectual Property Watch 1 Comment Although attempts to repeal last year’s healthcare reform bill and efforts to get the deficit under control may take up much of the United States Congress’ time this year, lawmakers are expected to tackle a number of intellectual property-related priorities lawmakers, including patent reform, internet neutrality, and enforcement during the new 112th session.
The 2011 Drug Patent ‘Cliff’ And The Evolution Of IP Valuation 11/01/2011 by Liza Porteus Viana, Intellectual Property Watch 1 Comment In today’s global economy, there is an increasing convergence of intellectual property and finance. Wall Street is grappling with how to recognise the true value of a firm’s intellectual property. Companies are realising that simply accumulating patents does not necessarily increase their firms’ value, but it is how those patents are used that can attract capital. And drug companies facing massive numbers of upcoming patent expiries, a deflated economy and other market pressures, are looking to diversify their portfolios to stay in the black.